Skip to main content
SpringerLink
Log in

What’s new on balanced crystalloid solutions?

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Reddy S, Weinberg L, Young P (2016) Crystalloid fluid therapy. Crit Care 20:1–9

    Article  Google Scholar 

  2. Martensson J, Bellomo R (2015) Are all fluids bad for the kidney? Curr Opin Crit Care 21:292–301

    Article  PubMed  Google Scholar 

  3. Bellomo R, Morimatsu H, French C, Cole L, Story D, Uchino S, Naka T, Investigators SS (2006) The effects of saline or albumin resuscitation on acid-base status and serum electrolytes. Crit Care Med 34:2891–2897

    Article  CAS  PubMed  Google Scholar 

  4. Weinberg L, Pearce B, Sullivan R, Siu L, Scurrah N, Tan C, Backstrom M, Nikfarjam M, McNicol L, Story D, Christophi C, Bellomo R (2014) The effects of plasmalyte-148 versus hartmann’s solution during major liver resection: a multicentre, double-blind, randomized controlled trial. Minerva Anestesiol 81(12):1288–1297

    PubMed  Google Scholar 

  5. Hammond NE, Taylor C, Saxena M, Liu B, Finfer S, Glass P, Seppelt I, Willenberg L, Myburgh J (2015) Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013. Intensive Care Med 41:1611–1619

    Article  CAS  PubMed  Google Scholar 

  6. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA (2012) Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg 255:821–829

    Article  PubMed  Google Scholar 

  7. Raghunathan K, Shaw A, Nathanson B, Sturmer T, Brookhart A, Stefan MS, Setoguchi S, Beadles C, Lindenauer PK (2014) Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med 42:1585–1591

    Article  CAS  PubMed  Google Scholar 

  8. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR (2014) Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med 40:1897–1905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD (2015) Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg 102:24–36

    Article  CAS  PubMed  Google Scholar 

  10. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA J Am Med Assoc 308:1566–1572

    Article  CAS  Google Scholar 

  11. Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS (2011) Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med 39:1335–1342

    Article  CAS  PubMed  Google Scholar 

  12. Shaw AD, Schermer CR, Lobo DN, Munson SH, Khangulov V, Hayashida DK, Kellum JA (2015) Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Crit Care 19:334

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161:347–355. doi:10.7326/M14-0178

    Article  PubMed  Google Scholar 

  14. Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Wludarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH, Group F (2015) Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 41:1561–1571

    Article  CAS  PubMed  Google Scholar 

  15. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R, Investigators S, Anzics CTG (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA J Am Med Assoc 314:1701–1710

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intensive Care Unit, Wellington Regional Hospital and the Medical Research Institute of New Zealand, Wellington, New Zealand

    Paul Young

  2. Anaesthesiology, Pain and Intensive Care Department, University of Sao Paulo, Sao Paulo, Brazil

    Flavia R. Machado

  3. Division of Critical Care and Trauma, The George Institute for Global Health, and University of Sydney, Sydney, Australia

    Simon Finfer

Authors
  1. Paul Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Flavia R. Machado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simon Finfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Young.

Ethics declarations

Funding

The Medical Research Institute of New Zealand receives Independent Research Organisation funding from the Health Research Council of New Zealand. Dr Young reports receiving partial funding for his institution to conduct the Saline vs. Plasma-Lyte 148® for ICU fluid therapy (SPLIT) study. The Plasma-Lyte 148® vs. Saline (PLUS) study is partially funded by Baxter. Professor Finfer declares his employers have received research funding and reimbursement of travel expenses from CSL Behring, Fresenius Kabi and Baxter.

Conflicts of interest

Professor Machado receives research funding from the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) and declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Young, P., Machado, F.R. & Finfer, S. What’s new on balanced crystalloid solutions?. Intensive Care Med 42, 2046–2048 (2016). https://doi.org/10.1007/s00134-016-4498-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-016-4498-x

Keywords

Search

Navigation